According to a new report from Intel Market Research, the global Micronized Acellular Dermal Matrix (mADM) market was valued at USD 320 million in 2025 and is projected to reach USD 580 million by 2034, growing at a steady CAGR of 6.5% during the forecast period (2026–2034). This expansion is driven by increasing demand for advanced wound care solutions, rising prevalence of chronic...